FIELD: pharmaceutics.
SUBSTANCE: compounds of formula (I) R1 is halogen atom; (C1-C6) alkyl, optionally substituted with one or more halogen atoms; (C1-C6) alkoxy group, optionally substituted with one or more halogen atoms, or -(CH2)nNHRa, where Ra represents hydrogen atom; -C(O)-(CH2)n-phenyl or -C(O)-(CH2)n-pyridyl, where phenyl is optionally substituted with one or more substitutes of halogen atom; -SCF3; (C1-C6)alkyl, optionally substituted with one or more halogen atoms, or (C1-C6)alkoxy group, optionally substituted with one or more halogen atoms; -C(O)-(C1-C8)alkyl, where alkyl is optionally substituted with one or more halogen atoms; -C(O)-(CH2)n-(C3-C10-cycloalkyl); -C(O)-(CH2)n-NRbRc, where Rb and Rc are hydrogen atoms independently of each other; (C1-C6)alkyl; or phenyl, optionally substituted with one or more substitutes of halogen atom or (C1-C6)alkyl; -C(O)-(CH2)n-O-(C1-C6)alkyl; or -C(O)-(CH2)n-O-(CH2)n-phenyl; R2 is hydrogen atom; OH; phenyl or (C1-C6) alkyl, optionally substituted with one or more halogen atoms; R3 is hydrogen atom; or (C1-C6) alkyl; and n takes values 0, 1 or 2.
EFFECT: method is disclosed of treating or controlling diseases or disorders, such as cancer involving administering 5-substituted quinazoline compound of formula (I) or its pharmaceutically acceptable salt, solvate or stereoisomer.
32 cl, 59 ex
| Title |
Year |
Author |
Number |
| 5-SUBSTITUTED QUINAZOLINONE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND METHODS FOR USING THEM |
2007 |
- Mjuller Dzhordzh V.
- Mehn Khon-Va
|
RU2463298C2 |
| 6-, 7- OR 8-SUBSTITUTED QUINAZOLINONE DERIVATIVES AND COMPOSITIONS CONTAINING THEM AND METHODS OF USING THEM |
2008 |
- Mjuller Dzhordzh V.
- Man Khon-Vakh
|
RU2476432C2 |
| ISOINDOLINE COMPOUNDS USED FOR TREATING CANCER |
2009 |
- Mjuller Dzhordzh V.
- Rachelmen Aleksander L.
|
RU2527952C2 |
| ARYLMETHOXY ISOINDOLIN DERIVATIVE, COMPOSITIONS INCLUDING THEREOF AND METHODS OF THEIR APPLICATION |
2011 |
- Man Khon-Vakh
- Mjuller Dzhordzh V.
- Rachelmen Aleksander
- Khalil Ehkhab M.
- Chehn' Rodzher Shehn'-Chu
- Chzhan Vehjkhun
|
RU2567753C2 |
| 4, O-SUBSTITUTED ISOINDOLINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND METHODS FOR USING THEM |
2008 |
- Rachelmen Aleksander L.
- Mjuller Dzhordzh V.
- Man Khon-Vakh
|
RU2471794C2 |
| CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS CONTAINING THEM |
2018 |
- Crew, Andrew, P.
- Berlin, Michael
- Dong, Hanqing
- Hornberger, Keith, R.
- Qian, Yimin
- Snyder, Lawrence, B.
- Wang, Jing
- Zimmermann, Kurt
|
RU2795146C2 |
| DERIVATIVES OF 7-OXO-1,6-DIAZABICYCLO[3.2.1]OCT-3-ENE, USEFUL FOR BACTERIAL INFECTIONS TREATMENT |
2013 |
- Makguajer Khelen
- Bist Shanta
- Bifalko Nejl
- Chzhao Lyan
- Vu Je
- Khuinkh Khoan
- Syun Khuej
- Komita-Prevuar Zhanell
- Dissolt Demian
- Gen Bolin
- Chen Brendan
- Dyuran-Reville Tomas
- Guler Satenig
|
RU2645678C2 |
| SUBSTITUTED 2,6-DIOXOPIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF DECREASE OF TUMOR NECROSIS FACTOR- LEVEL |
1997 |
- Maller Dzhordzh U.
- Sterling Dejvid I.
- Chen Rodzher Shen-Chu
|
RU2177944C2 |
| SUBSTITUTED 2,6-DIOXOPIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF DECREASE OF TUMOR NECROSIS FACTOR-α LEVEL |
1997 |
- Maller Dzhordzh U
- Sterling Dejvid I
- Chen Rodzher Shen-Chu
|
RU2595250C1 |
| SPIRO CONDENSED PYRROLIDINE DERIVATIVES AS INHIBITORS OF DEUBIQUITINATING ENZYMES (DUB) |
2017 |
- Kemp Mark Ien
- Stokli Martin Li
- Vudrou Majkl Devid
- Dzhons Elison
|
RU2730552C2 |
